Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank60
3Y CAGR-13.8%
5Y CAGR+0.9%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
-13.8%/yr
Quarterly compound
5Y CAGR
+0.9%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 8.05% |
| Q2 2025 | 37.55% |
| Q1 2025 | -67.93% |
| Q4 2024 | -30.98% |
| Q3 2024 | -0.81% |
| Q2 2024 | 9.57% |
| Q1 2024 | 23.93% |
| Q4 2023 | 9.75% |
| Q3 2023 | 6.00% |
| Q2 2023 | -7.31% |
| Q1 2023 | -13.46% |
| Q4 2022 | 9.47% |
| Q3 2022 | 12.57% |
| Q2 2022 | -18.85% |
| Q1 2022 | 17.04% |
| Q4 2021 | -18.69% |
| Q3 2021 | -1947.40% |
| Q2 2021 | 106.15% |
| Q1 2021 | -44.40% |
| Q4 2020 | 27.66% |
| Q3 2020 | 7.70% |
| Q2 2020 | 20.58% |
| Q1 2020 | 10.64% |
| Q4 2019 | -42.53% |
| Q3 2019 | 6.06% |
| Q2 2019 | -30.67% |
| Q1 2019 | -7.56% |
| Q4 2018 | -70.47% |
| Q3 2018 | -58.82% |
| Q2 2018 | 14.16% |
| Q1 2018 | 0.00% |